Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 15.16
(-0.72%)
CNY 15.16
(-0.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.66 Billion CNY | -0.38% |
| 2022 | 5.5 Billion CNY | 4.34% |
| 2021 | 5.27 Billion CNY | -4.46% |
| 2020 | 5.52 Billion CNY | -7.16% |
| 2019 | 5.94 Billion CNY | -8.68% |
| 2018 | 6.51 Billion CNY | 11.5% |
| 2017 | 5.84 Billion CNY | 14.7% |
| 2016 | 5.09 Billion CNY | -0.66% |
| 2015 | 5.12 Billion CNY | 8.58% |
| 2014 | 4.72 Billion CNY | 16.12% |
| 2013 | 4.06 Billion CNY | 42.52% |
| 2012 | 2.85 Billion CNY | 44.92% |
| 2011 | 1.96 Billion CNY | 25.59% |
| 2010 | 1.56 Billion CNY | 20.08% |
| 2009 | 1.3 Billion CNY | 14.65% |
| 2008 | 1.13 Billion CNY | 23.8% |
| 2007 | 919.64 Million CNY | 8.54% |
| 2006 | 847.25 Million CNY | 7.02% |
| 2005 | 791.66 Million CNY | -0.12% |
| 2004 | 792.6 Million CNY | 3.67% |
| 2003 | 764.51 Million CNY | 5.09% |
| 2002 | 727.5 Million CNY | 37.1% |
| 2001 | 530.62 Million CNY | 72.06% |
| 2000 | 308.38 Million CNY | 39.84% |
| 1999 | 220.52 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 1.36 Billion CNY | -8.41% |
| 2024 Q1 | 1.34 Billion CNY | 2.61% |
| 2024 Q2 | 1.49 Billion CNY | 10.67% |
| 2023 Q3 | 1.48 Billion CNY | -3.54% |
| 2023 Q1 | 1.36 Billion CNY | -12.25% |
| 2023 Q2 | 1.54 Billion CNY | 12.85% |
| 2023 FY | 5.48 Billion CNY | -0.38% |
| 2023 Q4 | 1.31 Billion CNY | -11.53% |
| 2022 Q2 | 1.43 Billion CNY | 22.66% |
| 2022 FY | 5.5 Billion CNY | 4.34% |
| 2022 Q4 | 1.55 Billion CNY | 15.48% |
| 2022 Q3 | 1.34 Billion CNY | -5.91% |
| 2022 Q1 | 1.16 Billion CNY | -19.97% |
| 2021 Q3 | 1.27 Billion CNY | -8.23% |
| 2021 Q2 | 1.39 Billion CNY | 21.75% |
| 2021 Q1 | 1.14 Billion CNY | -23.06% |
| 2021 FY | 5.27 Billion CNY | -4.46% |
| 2021 Q4 | 1.45 Billion CNY | 14.14% |
| 2020 Q1 | 1.2 Billion CNY | -20.84% |
| 2020 Q3 | 1.3 Billion CNY | -14.21% |
| 2020 Q4 | 1.48 Billion CNY | 13.92% |
| 2020 Q2 | 1.52 Billion CNY | 26.04% |
| 2020 FY | 5.52 Billion CNY | -7.16% |
| 2019 FY | 5.94 Billion CNY | -8.68% |
| 2019 Q3 | 1.29 Billion CNY | -17.19% |
| 2019 Q4 | 1.52 Billion CNY | 17.35% |
| 2019 Q1 | 1.55 Billion CNY | -18.63% |
| 2019 Q2 | 1.56 Billion CNY | 1.0% |
| 2018 Q4 | 1.9 Billion CNY | 17.33% |
| 2018 FY | 6.51 Billion CNY | 11.5% |
| 2018 Q3 | 1.62 Billion CNY | 0.53% |
| 2018 Q2 | 1.61 Billion CNY | 19.3% |
| 2018 Q1 | 1.35 Billion CNY | -35.23% |
| 2017 Q4 | 2.09 Billion CNY | 54.7% |
| 2017 FY | 5.84 Billion CNY | 14.7% |
| 2017 Q3 | 1.35 Billion CNY | 4.57% |
| 2017 Q1 | 1.09 Billion CNY | -39.78% |
| 2017 Q2 | 1.29 Billion CNY | 18.14% |
| 2016 Q1 | 972.88 Million CNY | -32.41% |
| 2016 FY | 5.09 Billion CNY | -0.66% |
| 2016 Q4 | 1.82 Billion CNY | 71.6% |
| 2016 Q3 | 1.06 Billion CNY | -14.31% |
| 2016 Q2 | 1.23 Billion CNY | 27.24% |
| 2015 Q4 | 1.43 Billion CNY | 17.02% |
| 2015 Q1 | 1.23 Billion CNY | -4.37% |
| 2015 FY | 5.12 Billion CNY | 8.58% |
| 2015 Q2 | 1.22 Billion CNY | -0.88% |
| 2015 Q3 | 1.22 Billion CNY | 0.58% |
| 2014 Q3 | 1.13 Billion CNY | -6.75% |
| 2014 Q2 | 1.21 Billion CNY | 11.87% |
| 2014 FY | 4.72 Billion CNY | 16.12% |
| 2014 Q4 | 1.29 Billion CNY | 13.99% |
| 2014 Q1 | 1.08 Billion CNY | -6.14% |
| 2013 Q3 | 985.47 Million CNY | -10.83% |
| 2013 Q1 | 818.75 Million CNY | -5.49% |
| 2013 FY | 4.06 Billion CNY | 42.52% |
| 2013 Q4 | 1.15 Billion CNY | 17.3% |
| 2013 Q2 | 1.1 Billion CNY | 34.99% |
| 2012 FY | 2.85 Billion CNY | 44.92% |
| 2012 Q4 | 866.28 Million CNY | 24.96% |
| 2012 Q2 | 649.39 Million CNY | 0.9% |
| 2012 Q1 | 643.58 Million CNY | 19.26% |
| 2012 Q3 | 693.23 Million CNY | 6.75% |
| 2011 Q1 | 418.64 Million CNY | -13.5% |
| 2011 FY | 1.96 Billion CNY | 25.59% |
| 2011 Q2 | 507.36 Million CNY | 21.19% |
| 2011 Q4 | 539.64 Million CNY | 7.35% |
| 2011 Q3 | 502.67 Million CNY | -0.92% |
| 2010 Q2 | 397.42 Million CNY | 30.03% |
| 2010 Q3 | 380.25 Million CNY | -4.32% |
| 2010 Q4 | 483.99 Million CNY | 27.28% |
| 2010 FY | 1.56 Billion CNY | 20.08% |
| 2010 Q1 | 305.64 Million CNY | -19.47% |
| 2009 Q3 | 337.67 Million CNY | -3.35% |
| 2009 FY | 1.3 Billion CNY | 14.65% |
| 2009 Q4 | 379.55 Million CNY | 12.4% |
| 2009 Q2 | 349.39 Million CNY | 46.42% |
| 2009 Q1 | 238.63 Million CNY | -26.22% |
| 2008 Q4 | 323.41 Million CNY | 9.46% |
| 2008 Q1 | 205.12 Million CNY | -24.38% |
| 2008 FY | 1.13 Billion CNY | 23.8% |
| 2008 Q2 | 314.46 Million CNY | 53.31% |
| 2008 Q3 | 295.47 Million CNY | -6.04% |
| 2007 FY | 919.64 Million CNY | 8.54% |
| 2007 Q2 | 250.56 Million CNY | 42.51% |
| 2007 Q1 | 175.82 Million CNY | -37.81% |
| 2007 Q3 | 221.98 Million CNY | -11.41% |
| 2007 Q4 | 271.27 Million CNY | 22.2% |
| 2006 Q3 | 178.56 Million CNY | -26.65% |
| 2006 Q4 | 282.7 Million CNY | 58.32% |
| 2006 Q1 | 142.54 Million CNY | -43.97% |
| 2006 FY | 847.25 Million CNY | 7.02% |
| 2006 Q2 | 243.44 Million CNY | 70.78% |
| 2005 FY | 791.66 Million CNY | -0.12% |
| 2005 Q1 | 125.85 Million CNY | -50.88% |
| 2005 Q4 | 254.4 Million CNY | 26.65% |
| 2005 Q3 | 200.87 Million CNY | -4.59% |
| 2005 Q2 | 210.52 Million CNY | 67.28% |
| 2004 Q1 | 128.9 Million CNY | -61.2% |
| 2004 Q3 | 202.14 Million CNY | -1.55% |
| 2004 Q4 | 256.22 Million CNY | 26.76% |
| 2004 FY | 792.6 Million CNY | 3.67% |
| 2004 Q2 | 205.33 Million CNY | 59.29% |
| 2003 FY | 764.51 Million CNY | 5.09% |
| 2003 Q4 | 332.25 Million CNY | 90.72% |
| 2003 Q3 | 174.21 Million CNY | 22.66% |
| 2003 Q1 | 116 Million CNY | -54.02% |
| 2003 Q2 | 142.02 Million CNY | 22.43% |
| 2002 Q1 | 110.95 Million CNY | 0.0% |
| 2002 Q2 | 178.44 Million CNY | 60.83% |
| 2002 FY | 727.5 Million CNY | 37.1% |
| 2002 Q3 | 185.82 Million CNY | 4.13% |
| 2002 Q4 | 252.28 Million CNY | 35.77% |
| 2001 FY | 530.62 Million CNY | 72.06% |
| 2000 FY | 308.38 Million CNY | 39.84% |
| 1999 FY | 220.52 Million CNY | 0.0% |